MS-DRG v44.0 · MDC 23: Factors Influencing Health Status and Other Contacts with Health Services
947 — Signs and Symptoms with MCC
- Relative weight
- 1.261
- Geometric mean LOS
- 3.6 days
- Arithmetic mean LOS
- 5.1 days
- Type
- Medical
About MS-DRG 947
MS-DRG 947, Signs and Symptoms with MCC, is a medical DRG in MDC 23 (Factors Influencing Health Status and Other Contacts with Health Services) under MS-DRG version 44.0, which applies to inpatient discharges from October 1, 2026 through September 30, 2027.
Its FY2027 relative weight is 1.261, so Medicare's base payment for this DRG is about 1.26 times the average inpatient case, before hospital-specific adjustments. The geometric mean length of stay is 3.6 days and the arithmetic mean is 5.1 days.
It belongs to a 2-level severity family: DRG 947 (with MCC, weight 1.261) and DRG 948 (without MCC, weight 0.7835). The highest-severity level carries 1.6 times the weight of the lowest, which is why documenting CC and MCC conditions matters.
It is subject to Medicare's post-acute care transfer policy, so payment can be reduced when a patient with a shorter-than-average stay is discharged to a skilled nursing facility, home health or another post-acute setting.
131 ICD-10-CM diagnosis codes are part of this DRG's grouping logic; they are listed below.
ICD-10-CM codes that group to DRG 947 (131)
Chapter 4: Endocrine, nutritional and metabolic diseases
Chapter 6: Diseases of the nervous system
Chapter 16: Certain conditions originating in the perinatal period
- P09.1Abnormal findings on neonatal screening for inborn errors of metabolism
- P09.2Abnormal findings on neonatal screening for congenital endocrine disease
- P09.3Abnormal findings on neonatal screening for congenital hematologic disorders
- P09.4Abnormal findings on neonatal screening for cystic fibrosis
- P09.5Abnormal findings on neonatal screening for critical congenital heart disease
- P09.6Abnormal findings on neonatal hearing screening
- P09.8Other abnormal findings on neonatal screening
- P09.9Abnormal findings on neonatal screening, unspecified
Chapter 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- R18.0Malignant ascites
- R18.8Other ascites
- R23.0Cyanosis
- R23.1Pallor
- R23.2Flushing
- R41.0Disorientation, unspecified
- R41.1Anterograde amnesia
- R41.2Retrograde amnesia
- R41.3Other amnesia
- R41.82Altered mental status, unspecified
- R41.9Unspecified symptoms and signs involving cognitive functions and awareness
- R45.83Excessive crying of child, adolescent or adult
- R45.84Anhedonia
- R52Pain, unspecified
- R53.0Neoplastic (malignant) related fatigue
- R53.1Weakness
- R53.2Functional quadriplegia
- R53.81Other malaise
- R53.82Chronic fatigue, unspecified
- R53.83Other fatigue
- R60.0Localized edema
- R60.1Generalized edema
- R60.9Edema, unspecified
- R64Cachexia
- R68.0Hypothermia, not associated with low environmental temperature
- R68.11Excessive crying of infant (baby)
- R68.12Fussy infant (baby)
- R68.81Early satiety
- R68.83Chills (without fever)
- R68.89Other general symptoms and signs
- R70.0Elevated erythrocyte sedimentation rate
- R70.1Abnormal plasma viscosity
- R74.01Elevation of levels of liver transaminase levels
- R74.02Elevation of levels of lactic acid dehydrogenase [LDH]
- R74.8Abnormal levels of other serum enzymes
- R74.9Abnormal serum enzyme level, unspecified
- R77.0Abnormality of albumin
- R77.1Abnormality of globulin
- R77.2Abnormality of alphafetoprotein
- R77.8Other specified abnormalities of plasma proteins
- R77.9Abnormality of plasma protein, unspecified
- R78.1Finding of opiate drug in blood
- R78.2Finding of cocaine in blood
- R78.3Finding of hallucinogen in blood
- R78.4Finding of other drugs of addictive potential in blood
- R78.5Finding of other psychotropic drug in blood
- R78.6Finding of steroid agent in blood
- R78.71Abnormal lead level in blood
- R78.72Abnormal gadolinium level in blood
- R78.79Finding of abnormal level of heavy metals in blood
- R78.89Finding of other specified substances, not normally found in blood
- R78.9Finding of unspecified substance, not normally found in blood
- R79.0Abnormal level of blood mineral
- R79.1Abnormal coagulation profile
- R79.81Abnormal blood-gas level
- R79.82Elevated C-reactive protein (CRP)
- R79.83Abnormal findings of blood amino-acid level
- R79.89Other specified abnormal findings of blood chemistry
- R79.9Abnormal finding of blood chemistry, unspecified
- R82.1Myoglobinuria
- R84.0Abnormal level of enzymes in specimens from respiratory organs and thorax
- R84.1Abnormal level of hormones in specimens from respiratory organs and thorax
- R84.2Abnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax
- R84.3Abnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax
- R84.4Abnormal immunological findings in specimens from respiratory organs and thorax
- R84.5Abnormal microbiological findings in specimens from respiratory organs and thorax
- R84.6Abnormal cytological findings in specimens from respiratory organs and thorax
- R84.7Abnormal histological findings in specimens from respiratory organs and thorax
- R84.8Other abnormal findings in specimens from respiratory organs and thorax
- R84.9Unspecified abnormal finding in specimens from respiratory organs and thorax
- R85.0Abnormal level of enzymes in specimens from digestive organs and abdominal cavity
- R85.1Abnormal level of hormones in specimens from digestive organs and abdominal cavity
- R85.2Abnormal level of other drugs, medicaments and biological substances in specimens from digestive organs and abdominal cavity
- R85.3Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity
- R85.4Abnormal immunological findings in specimens from digestive organs and abdominal cavity
- R85.5Abnormal microbiological findings in specimens from digestive organs and abdominal cavity
- R85.69Abnormal cytological findings in specimens from other digestive organs and abdominal cavity
- R85.7Abnormal histological findings in specimens from digestive organs and abdominal cavity
- R85.89Other abnormal findings in specimens from digestive organs and abdominal cavity
- R85.9Unspecified abnormal finding in specimens from digestive organs and abdominal cavity
- R87.0Abnormal level of enzymes in specimens from female genital organs
- R87.1Abnormal level of hormones in specimens from female genital organs
- R87.2Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs
- R87.3Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs
- R87.4Abnormal immunological findings in specimens from female genital organs
- R87.5Abnormal microbiological findings in specimens from female genital organs
- R87.618Other abnormal cytological findings on specimens from cervix uteri
- R87.619Unspecified abnormal cytological findings in specimens from cervix uteri
- R87.629Unspecified abnormal cytological findings in specimens from vagina
- R87.69Abnormal cytological findings in specimens from other female genital organs
- R87.7Abnormal histological findings in specimens from female genital organs
- R87.89Other abnormal findings in specimens from female genital organs
- R87.9Unspecified abnormal finding in specimens from female genital organs
- R88.0Cloudy (hemodialysis) (peritoneal) dialysis effluent
- R88.8Abnormal findings in other body fluids and substances
- R89.0Abnormal level of enzymes in specimens from other organs, systems and tissues
- R89.1Abnormal level of hormones in specimens from other organs, systems and tissues
- R89.2Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues
- R89.3Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues
- R89.4Abnormal immunological findings in specimens from other organs, systems and tissues
- R89.5Abnormal microbiological findings in specimens from other organs, systems and tissues
- R89.6Abnormal cytological findings in specimens from other organs, systems and tissues
- R89.7Abnormal histological findings in specimens from other organs, systems and tissues
- R89.8Other abnormal findings in specimens from other organs, systems and tissues
- R90.89Other abnormal findings on diagnostic imaging of central nervous system
- R93.89Abnormal findings on diagnostic imaging of other specified body structures
- R93.9Diagnostic imaging inconclusive due to excess body fat of patient
- R97.0Elevated carcinoembryonic antigen [CEA]
- R97.1Elevated cancer antigen 125 [CA 125]
- R97.20Elevated prostate specific antigen [PSA]
- R97.21Rising PSA following treatment for malignant neoplasm of prostate
- R97.8Other abnormal tumor markers
Chapter 21: Factors influencing health status and contact with health services
Common questions about DRG 947
What is the relative weight of DRG 947?
- 1.261 for FY2027 (MS-DRG v44.0), from the IPPS final rule Table 5.
What is the average length of stay for DRG 947?
- The geometric mean length of stay is 3.6 days; the arithmetic mean is 5.1 days.
Is DRG 947 medical or surgical?
- DRG 947 is a medical DRG.